Please use this identifier to cite or link to this item: http://hdl.handle.net/11455/13056
標題: 鴨肝炎病毒一型VP1蛋白酵素連結免疫吸附分析(ELISA)套組開發與單源抗體製備
Development of ELISA Kit and Monoclonal Antibody for Duck Hepatitis A Virus VP1 Protein
作者: 王韻婷
Wang, Yun-Ting
關鍵字: Duck Hepatitis A Virus
鴨肝炎
ELISA
Monoclonal Antibody
酵素連結免疫吸附分析
單源抗體
出版社: 獸醫學系暨研究所
引用: 丁彥文。2004。應用反轉錄聚合酶鏈反應技術檢測鴨小RNA病毒及台灣地區鳥禽血清學調查。國立台灣大學獸醫學研究所。台灣台北市。中華民國。 余玓澄。2007。家禽流行性感冒病毒血球凝集素單源抗體之建立及特性分析。國立中興大學獸醫微生物學研究所。台灣台中市。中華民國。 陳亮丞。2004。家禽流行性感冒病毒核蛋白之核酸序列分析與酵素連結免疫吸附分析(ELISA)套組之開發。國立中興大學獸醫學研究所。台灣台中市。中華民國。 施雨華。2007。製備抗家禽流行性感冒病毒H6亞型血球凝集素之單源抗體。國立中興大學獸醫學研究所。台灣台中市。中華民國。 Asplin FD. Duck hepatitis. Vaccination against two serological types. Vet Rec 77:1529–1530, 1965. Anchun C, Mingshu W, Hongyi X, Dekang Z, Xinran L, Haijuen C, Renyong J, Miao Y. Development and application of a reverse transcriptase polymerase chain reaction to detect Chinese isolates of duck hepatitis virus type 1. J Microbiol Methods 77:332-6, 2009. Branden C, Tooza J. Bata structures. In: Introduction to protein structure, 2nd ed. Garland Publishing, New York. P.67-88, 1999. Crighton GW, Woolcock PR. Active immunisation of ducklings against duck virus hepatitis. Vet Rec 102:358-61, 1978. Clavijo A, Thorsen J. Bacterial expression of the caprine arthritis-encephalitis virus gag and env proteins and their use in enzyme-linked immunosorbent assay. Am J Vet Res 56:841-8, 1995. Clavijo A, Zhou EM, Hole K, Galic B, Kitching P. Development and use of a biotinylated 3ABC recombinant protein in a solid-phase competitive ELISA for the detection of antibodies against foot-and-mouth disease virus. J Virol Methods 120:217-27, 2004. Cova L. DNA-designed avian IgY antibodies: novel tools for research, diagnostics and therapy. J Clin Virol 1:S70-4, 2005. Crighton GW, Woolcock PR. Active immunisation of ducklings against duck virus hepatitis.Vet Rec 102:358-61, 1978. De St Groth DR, Scheidegger D. Production of monoclonal antibodies:strategy and tactics. J Immuno Meth 35:1-21, 1980. Ding C, Zhang D. Molecular analysis of duck hepatitis virus type 1. Virology 361:9-17, 2007. Fitzgerald JE, Hanson LE. Certain properties of a cell-culture-modified duck hepatitis virus. Avian Dis 10:157-61, 1966. Fu Y, Pan M, Wang X, Xu Y, Yang H, Zhang D. Molecular detection and typing of duck hepatitis A virus directly from clinical specimens. Vet Microbiol 131:247-57, 2008. Gabridge MG, Newman JP. Gel diffusion method for determining the titer of duck hepatititis virus. Appl Microbiol 21:147-8, 1971. Gao SD, Du JZ, Chang HY, Cong GZ, Shao JJ, Lin T, Song S, Xie QG. B cell epitopes within VP1 of type O foot-and-mouth disease virus for detection of viral antibodies. Virol Sin 25:18-26, 2010. Goldsby RA. A practical guide to making hybridoma. In:Swaminathan B, Prakash G(ed.). Nucleic acid and monoclonal antibody probes. Marrcel Dekker, Inc. New York, N. Y. p.367-382, 1989. Gough RE, Spackman D. Studies with inactivated duck virus hepatitis vaccines in breeder ducks. Avian Pathol 10:471-9, 1981. Hwang J. Duck hepatitis virus in duck embryo liver cell cultures. Avian Dis 10:508-12, 1966. Hwang J. Duck hepatitis virus-neutralization test in chicken embryos. Am. J. Vet. Res 30:861-864, 1969. Jia R, Cheng A, Wang M, Qi X, Zhu D, Ge H, Luo Q, Liu F, Guo Y, Chen X. Development and evaluation of an antigen-capture ELISA for detection of the UL24 antigen of the duck enteritis virus, based on a polyclonal antibody against the UL24 expression protein. J Virol Method 161:38-43, 2009. Jin X, Zhang W, Zhang W, Gu C, Cheng G, Hu X. Identification and molecular analysis of the highly pathogenic duck hepatitis virus type 1 in Hubei province of China.Res Vet Sci 85:595-8, 2008. Kaleta EF. Duck viral hepatitis type 1 vaccination: monitoring of the immune response with a microneutralisation test in Pekin duck embryo kidney cell cultures. Avian Pathol 17:325-32, 1988. Kang MS, Jang H, Kim MC, Kim MJ, Joh SJ, Kwon JH, Kwon YK. Development of a stabilizer for lyophilization of an attenuated duck viral hepatitis vaccine. Poult Sci 89:1167-70, 2010. Kardi V, Szegletes E. Use of ELISA procedures for the detection of Derzsy''s disease virus of geese and of antibodies produced against it. Avian Pathol 25:25-34, 1996. Kim MC, Kwon YK, Joh SJ, Lindberg AM, Kwon JH, Kim JH, Kim SJ. Molecular analysis of duck hepatitis virus type 1 reveals a novel lineage close to the genus Parechovirus in the family Picornaviridae. J Gen Virol 87:3307-16, 2006. Kim MC, Kwon YK, Joh SJ, Kwon JH, Kim JH, Kim SJ. Development of one-step reverse transcriptase-polymerase chain reaction to detect duck hepatitis virus type 1. Avian Dis 51:540-5, 2007. Kim MC, Kwon YK, Joh SJ, Kim SJ, Tolf C, Kim JH, Sung HW, Lindberg AM, Kwon JH. Recent Korean isolates of duck hepatitis virus reveal the presence of a new geno- and serotype when compared to duck hepatitis virus type 1 type strains. Arch Virol 152:2059-72, 2007. Kim MC, Kwon YK, Joh SJ, Kwon JH, Lindberg AM. Differential diagnosis between type-specific duck hepatitis virus type 1 (DHV-1) and recent Korean DHV-1-like isolates using a multiplex polymerase chain reaction. Avian Pathol 37:171-7, 2008. Kim MC, Kim MJ, Kwon YK, Lindberg AM, Joh SJ, Kwon HM, Lee YJ, Kwon JH. Development of duck hepatitis A virus type 3 vaccine and its use to protect ducklings against infections. Vaccine 27:6688-94, 2009. Lee HS, Heo EJ, Jeoung HY, Ko HR, Kweon CH, Youn HJ, Ko YJ. Enzyme-linked immunosorbent assay using glycoprotein and monoclonal antibody for detecting antibodies to vesicular stomatitis virus serotype New Jersey. Clin Vaccine Immunol 16:667-71, 2009. Levine PP, Fabricant J. A hitherto-undescribed virus disease of ducks in North America. Cornell Vet 40:71-86, 1950. Liao YK, Lu YS, Lin YL, Lee SH, Chiu SY. The outbreak and control of duck viral disease in Taiwan, 1989-90. Department of epidemiology, Taiwan provincial research institute for animal health, 2001. Liu G, Wang F, Ni Z, Yun T, Yu B, Huang J, Chen J. Genetic diversity of the VP1 gene of duck hepatitis virus type I (DHV-I) isolates from southeast China is related to isolate attenuation. Virus Res 137:137-41, 2008. Liu M, Zhang T, Zhang Y, Meng F, Li X, Hou Z, Feng X, Kong X. Development and evaluation of a VP1-ELISA for detection of antibodies to duck hepatitis type 1 virus. J Virol Methods 169:66-9, 2010. Lu H. A longitudinal study of a novel dot-enzyme-linked immunosorbent assay for detection of avian influenza virus. Avian Dis 47:361-9, 2003. McFerran JB, McNulty MS, Curran WL. Diagnosis of avian viral diseases by electron microscopy. American Journal of Veterinary Research 39:505-508, 1978. Morioka K, Fukai K, Yoshida K, Yamazoe R, Onozato H, Ohashi S, Tsuda T, Sakamoto K. Foot-and-mouth disease virus antigen detection enzyme-linked immunosorbent assay using multiserotype-reactive monoclonal antibodies. J Clin Microbiol 47:3663-8, 2009. Murphy FA, Gibbs EP, Horzinek MC. Veterinary virology 3th ed. 1999. OIE, 2008. Duck virus hepatitis. In:Manual of Diagnostic Tests and Vaccines for Terrestrial Animals. Part 2. Section 2.3. Chapter 2.3.8. http://www.oie.int/fileadmin/Home/eng/Health_standards/tahm/2008/pdf/2.03.08_DVH.pdf Ren XG, Xue F, Zhu YM, Tong GZ, Wang YH, Feng JK, Shi HF, Gao YR. Construction of a recombinant BHV-1 expressing the VP1 gene of foot and mouth disease virus and its immunogenicity in a rabbit model. Biotechnol Lett 31:1159-65, 2009. Richter WR, Rdzok EJ, Mozie SM. Electron microscopy of virus-like particles associated with duck viral hepatitis. Virology 24:114-6, 1964. Robiolo B, La Torre J, Maradei E, Beascoechea CP, Perez A, Seki C, Smitsaart E, Fondevila N, Palma E, Goris N, De Clercq K, Mattion N. Confidence in indirect assessment of foot-and-mouth disease vaccine potency and vaccine matching carried out by liquid phase ELISA and virus neutralization tests. Vaccine 28:6235-41, 2010. Rossmann MG, Arnold E, Erickson JW, Frankenberger EA, Griffith JP, Hecht HJ, Johnson JE, Kamer G, Luo M, Mosser AG, et al. Structure of a human common cold virus and functional relationship to other picornaviruses. Nature 317:145-53,1985. Sandhu TS, Calnek BW, Zeman L. Pathologic and serologic characterization of a variant of duck hepatitis type I virus. Avian Dis 36:932-6, 1992. Snyder DB, Marquardt WW, Yancey FS, Savage PK. An enzyme-linked immunosorbent assay for the detection of antibody against avian influenza virus. Avian Dis 29:136-44, 1985. Tauraso NM, Coghill GE, Klutch MJ. Properties of the attenuated vaccine strain of duck hepatitis virus. Avian Dis 13:321-329, 1969. Taylor PL, Hanson LE. Indirect hemagglutination with duck hepatitis virus. Avian Dis 11:586-93,1967. Todd D, Smyth VJ, Ball NW, Donnelly BM, Wylie M, Knowles NJ, Adair BM. Identification of chicken enterovirus-like viruses, duck hepatitis virus type 2 and duck hepatitis virus type 3 as astroviruses. Avian Pathol 38:21-30, 2009. Tomita M, Tsumoto K. Hybridoma technologies for antibody production. Immunotherapy 3:371-80, 2011. Toth TE. Studies of an agent causing mortality among ducklings immune to duck virus hepatitis. Avian Dis 13:834-46, 1969. Tseng CH, Knowles NJ, Tsai HJ. Molecular analysis of duck hepatitis virus type 1 indicates that it should be assigned to a new genus.Virus Res 123:190-203, 2007. Tseng CH, Tsai HJ. Molecular characterization of a new serotype of duck hepatitis virus. Virus Res 126:19-31, 2007. Wang L, Pan M, Fu Y, Zhang D. Classification of duck hepatitis virus into three genotypes based on molecular evolutionary analysis. Virus Genes 37:52-9, 2008. Woolcock PR, Crighton GW. Duck virus hepatitis: serial passage of attenuated virus in ducklings. Vet Rec 105:30-2, 1979. Woolcock PR, Crighton GW. Duck virus hepatitis: the effect of attenuation on virus stability in ducklings. Avian Pathol 10:113-9, 1981. Woolcock PR, Chalmers WSK, Davis D. A plaque assay for duck hepatitis virus. Avian Pathol 11:607-610, 1982. Woolcock PR. Duck hepatitis virus type I: studies with inactivated vaccines in breeder ducks. Avian Pathol 20:509-22, 1991. Woolcock PR. Duck virus hepatitis. In:Disease of Poultry, 11th edition. Edited by YM Saif, Bares JR, Glisson AM, Fadly LR, McDougald LR and DE. Iowa State Press, Ames, IA: 343-354, 2003. Yang M, Cheng A, Wang M, Xing H. Development and application of a one-step real-time Taqman RT-PCR assay for detection of Duck hepatitis virus type1. J Virol Methods 153:55-60, 2008. Yun T, Ni Z, Liu GQ, Yu B, Chen L, Huang JG, Zhang YM, Chen JP. Generation of infectious and pathogenic duck hepatitis virus type 1 from cloned full-length cDNA. Virus Res 147:159-65, 2010. Zoah XL, Phillips RM, Li GD, Zhong AQ. Studies on the detection of antibody to duck hepatitis virus by enzyme-linked immunosorbent assay. Avian Dis 35;778-782, 1991.
摘要: 鴨肝炎病毒一型(DHAV-1)是一種在雛鴨高度致死性疾病,台灣曾經在1972年及1990年分別爆發大流行。在本研究中先利用血清中和試驗調查2010年台灣的一日齡雛鴨與待售成鴨血清中DHAV-1中和抗體力價,其抗體陽性率分別為18.78 %及10.5 %,證明在台灣鴨場環境中仍有DHAV-1野外毒株持續潛伏。因此利用鴨肝炎病毒一型野外分離株之VP1蛋白進行DHAV-1 抗體ELISA檢測系統的建構,期望可以取代傳統的血清中和試驗,減少檢測所需耗費的時間。首先使用原核E.coli表現系統表現並純化VP1蛋白,再以DHAV-1高免血清及陰性鴨隻血清使用於西方墨點法來確認VP1蛋白的特異性。相對於血清中和試驗,使用純化VP1蛋白建構的ELISA之相對敏感性為與相對特異性分別為100 %與94.64 %,一致性則為0.93。顯示將純化VP1蛋白使用於ELISA與血清中和試驗一樣具有良好的特異性,且需要耗費的時間較短,所以使用VP1蛋白建立ELISA檢測套組可達到快速且大量檢測抗體樣本的目的。進一步實驗利用所純化的DHAV-1重組蛋白VP1免疫BALB/C小鼠,來製備出針對DHAV-1 VP1蛋白的單源抗體,未來可將其應用於檢測套組開發。經過細胞融合、多次篩選和單株化後共篩選出1株具有特異性分泌抗VP1蛋白抗體能力且敏感性佳的單株抗體,以dot-enzyme-linked immunosorbent assay評估所製備的單源抗體2C2有良好的敏感性,由間接免疫螢光染色法與免疫過氧化酶單層細胞分析法證明單源抗體2C2具有良好特異性。因此本實驗所製備之單源抗體未來可應用於開發診斷試劑,有利於DHAV-1的監控。
Duck hepatitis A virus type I is a highly fatal disease of young duckling. In Taiwan two epidemics of duck viral hepatitis occurred in 1972 and 1990. Therefore, development of a fast and sensitive method to detect DHAV-1 is essential to control the disease. In this study, serum neutralization test was used to investigate the neutralize antibody titer for adult duck and one day duck. The positive rate of antibody titer is 18.7 % and 10.5 %. It was proved wild-type DHAV-1 was still in natural environment. A simple and reliable ELISA for detecting DHAV-1 specific antibodies using DHAV-1 VP1 protein expressed from E. coli as a coating antigen was developed in order to replace traditional antibody determination. The sensitivity and specificity of the ELISA were evaluated in comparison with serum neutralization tests. The sensitivity and specificity were found to be 100% and 94.46 %, respectively. The kappa value between the two methods was 0.93. The results suggest that the VP1-based ELISA has advantages over conventional serum neutralization tests and may be applied for detection of a larger number of samples. In order to further increase sensitivity and specificity for detecting DHAV-1, we attempted to develop VP1 protein-based monoclonal antibody named 2C2. Thus far, the synthesized VP1 monoclonal antibody has both sensitivity and specificity against VP1 protein as determined by dot-enzyme-linked immunosorbent, IFA and IPMA. Taken together, our current results suggest that DHAV-1 VP1 protein-based monoclonal antibody has potential to develop new detection tools for DHAV-1 surveillance.
URI: http://hdl.handle.net/11455/13056
其他識別: U0005-2706201113475600
文章連結: http://www.airitilibrary.com/Publication/alDetailedMesh1?DocID=U0005-2706201113475600
Appears in Collections:獸醫學系所

文件中的檔案:

取得全文請前往華藝線上圖書館



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.